Anavex Life Sciences Corp.
USD2.65
-0.14 (-5.03%)
CEO
Christopher U. Missling
IPO Date
2006-08-02
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.73
Prev. Close
$2.79
Day Low
$2.61
Day High
$2.75
52W Low
$2.61
52W High
$13.99
Market Cap
$0.25B
Volume
1.05M
| 7,500 |
| $5.36 |
| 14 May 2026 | Kellmeyer Terrie | Interim CEO | Disposed | 50,000 | $8.58 |
| 1 May 2026 | Paeger Axel | director: | Disposed | 0 | $0.00 |
| 9 Jan 2026 | MISSLING CHRISTOPHER U | director, officer: President and CEO | A-Award | Acquired | 125,000 | $8.58 |
| 9 Jan 2026 | Boenisch Sandra | PFO & Treasurer | A-Award | Acquired | 12,500 | $8.58 |
| 3 Oct 2025 | Boenisch Sandra | PFO & Treasurer | A-Award | Acquired | 12,500 | $5.36 |
| 3 Oct 2025 | MISSLING CHRISTOPHER U | director, officer: President and CEO | A-Award | Acquired | 125,000 | $5.36 |
| 12 Sept 2025 | MISSLING CHRISTOPHER U | director, officer: President and CEO | M-Exempt | Acquired | 187,500 | $5.04 |
| 12 Sept 2025 | MISSLING CHRISTOPHER U | director, officer: President and CEO | F-InKind | Disposed | 145,048 | $9.58 |